BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 18, 2015
View Archived Issues
Topline results from exploratory study of Dextenza for inflammatory dry eye disease
Read More
Seres Therapeutics starts phase I trial of microbiome therapeutic SER-287 in UC
Read More
Pharnext begins phase III study of PXT-3003 for Charcot-Marie-Tooth disease type 1A
Read More
EPPS disaggregrates beta-amyloid plaques in mouse models of Alzheimer's disease
Read More
Bristol-Myers Squibb collaborates with UCLA within I-O RPM research program
Read More
Yisheng Biopharma collaborates with USAMRIID on Ebola vaccine
Read More
Novogene and Illumina to codevelop diagnostic for prenatal DNA and oncology testing in China
Read More
Chinese researchers report Nek2 inhibitor for gastrointestinal cancer
Read More
Phase III trial of KIT-302 meets primary efficacy endpoint
Read More
Rosetta and Biocept complete collaborative feasibility studies
Read More
Merck & Co. responds after conclusion of FDA advisory committee meeting on Vytorin
Read More
Sanford-Burnham Medical Research Institute introduces apelin receptor agonists
Read More
Cancer Research UK, Oregon Health & Science University collaborate on early cancer detection
Read More
Let-7g miRNA shows potential as a therapeutic target for hepatitis C
Read More
Athenex updates on its pipeline development and its acquisitions
Read More
StARD1 may be a novel therapeutic target for alcohol-driven liver disease
Read More
PEGylated rh arginase inhibits glioma cell growth
Read More
Oryzon Genomics files for clinical trial of ORY-2001 in Spain
Read More
Acerta reports results from phase I/II trial of acalabrutinib in relapsed CLL and SLL
Read More
Angiotensin AT2 receptor agonist prevents cancer cachexia in animal models
Read More
Helsinn's ghrelin receptor agonist HM-01 shows activity in preclinical models of cancer cachexia
Read More
ARQ-087 receives FDA orphan drug designation for cholangiocarcinoma
Read More
Isis Pharmaceuticals confirms initiation of phase II study of ISIS-TTR-Rx
Read More
Biogen patents autotaxin inhibitors
Read More
AstraZeneca acquires ZS Pharma
Read More
Imlygic approved in E.U. for unresectable melanoma that is distantly or regionally metastatic
Read More
Bridion from Merck & Co. receives approval for the reversal of neuromuscular blockade
Read More
CareDx to acquire transplantation diagnostics company Allenex
Read More
FDA approves Tris Pharma's extended-release chewable tablet formulation
Read More
OXiGENE's OXi-4503 receives E.U. orphan drug designation for AML
Read More